Feb 14 (Reuters) - GI Dynamics Inc GIDYL.PK :
* RECEIVED INSTITUTIONAL REVIEW BOARD APPROVAL TO CONDUCT ITS PIVOTAL TRIAL OF ENDOBARRIER FOR TYPE 2 DIABETES AND OBESITY
Feb 14 (Reuters) - GI Dynamics Inc GIDYL.PK :
* RECEIVED INSTITUTIONAL REVIEW BOARD APPROVAL TO CONDUCT ITS PIVOTAL TRIAL OF ENDOBARRIER FOR TYPE 2 DIABETES AND OBESITY